Emerging Protein Biotherapeutics
eBook - PDF

Emerging Protein Biotherapeutics

  1. 368 pages
  2. English
  3. PDF
  4. Available on iOS & Android
eBook - PDF

Emerging Protein Biotherapeutics

About this book

Given the speed at which antibody therapy is becoming readily accepted, a comprehensive industry guide is sorely needed. Written by leading international authorities, this book maintains an overall emphasis on various therapeutic approaches and applications and provides critical discussions on the most significant areas of research in biologics. It focuses on the applications of protein biologics in autoimmunity and inflammation, hematological malignancies, and solid tumors. Each chapter clearly presents the most informative and contemporary account of its subject available, making this an unrivaled reference source beneficial to those in both academia and biotechnology industries.

Frequently asked questions

Yes, you can cancel anytime from the Subscription tab in your account settings on the Perlego website. Your subscription will stay active until the end of your current billing period. Learn how to cancel your subscription.
No, books cannot be downloaded as external files, such as PDFs, for use outside of Perlego. However, you can download books within the Perlego app for offline reading on mobile or tablet. Learn more here.
Perlego offers two plans: Essential and Complete
  • Essential is ideal for learners and professionals who enjoy exploring a wide range of subjects. Access the Essential Library with 800,000+ trusted titles and best-sellers across business, personal growth, and the humanities. Includes unlimited reading time and Standard Read Aloud voice.
  • Complete: Perfect for advanced learners and researchers needing full, unrestricted access. Unlock 1.4M+ books across hundreds of subjects, including academic and specialized titles. The Complete Plan also includes advanced features like Premium Read Aloud and Research Assistant.
Both plans are available with monthly, semester, or annual billing cycles.
We are an online textbook subscription service, where you can get access to an entire online library for less than the price of a single book per month. With over 1 million books across 1000+ topics, we’ve got you covered! Learn more here.
Look out for the read-aloud symbol on your next book to see if you can listen to it. The read-aloud tool reads text aloud for you, highlighting the text as it is being read. You can pause it, speed it up and slow it down. Learn more here.
Yes! You can use the Perlego app on both iOS or Android devices to read anytime, anywhere — even offline. Perfect for commutes or when you’re on the go.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app.
Yes, you can access Emerging Protein Biotherapeutics by Iqbal S. Grewal in PDF and/or ePUB format, as well as other popular books in Medicine & Biotechnology in Medicine. We have over one million books available in our catalogue for you to explore.

Information

Publisher
CRC Press
Year
2009
Print ISBN
9781420063202
eBook ISBN
9781420063219

Table of contents

  1. Front cover
  2. Contents
  3. Preface
  4. About the Editor
  5. Contributors
  6. Section I: Introduction
  7. Chapter 1. Overview of Antibody- Based Therapeutics: Present and Future Promise
  8. Section II: Biologics for Autoimmunity and Imflammation
  9. Chapter 2. Biologic Therapies for Multiple Sclerosis
  10. Chapter 3. Biologic Therapies in Rheumatoid Arthritis
  11. Chapter 4. Biologic Therapies in Systemic Lupus Erythematosus
  12. Chapter 5. Biologic Therapies for Inflammatory Bowel Disease
  13. Chapter 6. Biologic Therapies for Psoriasis
  14. Chapter 7. TNFα Inhibitors: Emerging Biologic Therapies for the Treatment of Asthma
  15. Chapter 8. Protein-Based Therapies in Experimental and Clinical Transplantation
  16. Chapter 9. Biologic Therapies for Type 1 Diabetes
  17. Section III: Biologics for Hematological Malignancies
  18. Chapter 10. Biologic Therapies for Acute Myeloid Leukemia/ Myelodysplastic Syndrome
  19. Chapter 11. Biologic Therapies for Non-Hodgkin Lymphoma and Hodgkin Disease
  20. Chapter 12. Biologic Therapies for Chronic Lymphocytic Leukemia
  21. Chapter 13. Biologic Therapies for Multiple Myeloma and Plasma Cell Disorders
  22. Section IV: Development of Biotherapies for Solid Tumors
  23. Chapter 14. Antibody-Based Therapies for Carcinomas
  24. Chapter 15. Role of Vascular Targeting Agents in the Treatment of Solid Tumors: Current and Future Developments
  25. Chapter 16. Recent Advancements in the Use of Antibody– Drug Conjugates for Cancer Therapy
  26. Index
  27. Back cover